Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tomida

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Anti-Cancer Drug Design|July 16, 1999
Drug resistance mediated by cellular stress response to the microenvironment of solid tumorsA Tomida, T Tsuruo
Anti-Cancer Drugs|April 1, 1995
Multidrug resistanceT Tsuruo, A Tomida
Japanese Journal of Cancer Research : Gann|November 1, 1990
Synergistic effect in culture of bleomycin-group antibiotics and N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine, a synthetic isoprenoidA Tomida, H Suzuki
Japanese Journal of Cancer Research : Gann|January 1, 1991
Novel mechanism of N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine in potentiation of antitumor drug action on multidrug-resistant and sensitive Chinese hamster cellsA Tomida, T Tatsuta, H Suzuki
International Journal of Cancer|November 4, 1996
Glucose-regulated stresses induce resistance to camptothecin in human cancer cellsA Tomida, J Yun, T Tsuruo
Japanese Journal of Cancer Research : Gann|January 23, 1999
A novel mutant from apoptosis-resistant colon cancer HT-29 cells showing hyper-apoptotic response to hypoxia, low glucose and cisplatinH Suzuki, A Tomida, T Tsuruo
Japanese Journal of Cancer Research : Gann|February 1, 1995
Acute induction of adriamycin-resistance in human colon carcinoma HT-29 cells exposed to a sublethal dose of adriamycinA Tomida, M Naito, T Tsuruo
Oncogene|October 11, 2001
Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxiaH Suzuki, A Tomida, T Tsuruo
Japanese Journal of Cancer Research : Gann|March 1, 1990
Cytocidal activity of a synthetic isoprenoid, N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine, and its potentiation of antitumor drugs against multidrug-resistant and sensitive cells in vitroH Suzuki, A Tomida, T Nishimura
Oncology Research|January 1, 1995
Glucose-regulated stresses confer resistance to VP-16 in human cancer cells through a decreased expression of DNA topoisomerase IIJ Yun, A Tomida, K Nagata, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Anti-Cancer Drug Design|July 16, 1999
Drug resistance mediated by cellular stress response to the microenvironment of solid tumorsA Tomida, T Tsuruo
Anti-Cancer Drugs|April 1, 1995
Multidrug resistanceT Tsuruo, A Tomida
Japanese Journal of Cancer Research : Gann|November 1, 1990
Synergistic effect in culture of bleomycin-group antibiotics and N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine, a synthetic isoprenoidA Tomida, H Suzuki
Japanese Journal of Cancer Research : Gann|January 1, 1991
Novel mechanism of N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine in potentiation of antitumor drug action on multidrug-resistant and sensitive Chinese hamster cellsA Tomida, T Tatsuta, H Suzuki
International Journal of Cancer|November 4, 1996
Glucose-regulated stresses induce resistance to camptothecin in human cancer cellsA Tomida, J Yun, T Tsuruo
Japanese Journal of Cancer Research : Gann|January 23, 1999
A novel mutant from apoptosis-resistant colon cancer HT-29 cells showing hyper-apoptotic response to hypoxia, low glucose and cisplatinH Suzuki, A Tomida, T Tsuruo
Japanese Journal of Cancer Research : Gann|February 1, 1995
Acute induction of adriamycin-resistance in human colon carcinoma HT-29 cells exposed to a sublethal dose of adriamycinA Tomida, M Naito, T Tsuruo
Oncogene|October 11, 2001
Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxiaH Suzuki, A Tomida, T Tsuruo
Japanese Journal of Cancer Research : Gann|March 1, 1990
Cytocidal activity of a synthetic isoprenoid, N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine, and its potentiation of antitumor drugs against multidrug-resistant and sensitive cells in vitroH Suzuki, A Tomida, T Nishimura
Oncology Research|January 1, 1995
Glucose-regulated stresses confer resistance to VP-16 in human cancer cells through a decreased expression of DNA topoisomerase IIJ Yun, A Tomida, K Nagata, et al.
Pageof 4